Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

APA

CBE

MLA

Vancouver

Author

Bibtex

@article{ecb54381b5ac420689649e8620b5e75c,
title = "Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic",
keywords = "Betacoronavirus, Clinical Trials as Topic, Coronavirus Infections/complications, Disease Management, Disease Susceptibility, Humans, Immunoglobulins, Intravenous/therapeutic use, Immunologic Factors/therapeutic use, Immunosuppressive Agents/therapeutic use, Immunotherapy, Lambert-Eaton Myasthenic Syndrome/complications, Myasthenia Gravis/complications, Pandemics, Plasma Exchange, Pneumonia, Viral/complications, Vaccines, COVID-19, SARS-CoV-2",
author = "Saiju Jacob and Srikanth Muppidi and Amanda Guidon and Jeffrey Guptill and Michael Hehir and Howard, {James F} and Isabel Illa and Renato Mantegazza and Hiroyuki Murai and Kimiaki Utsugisawa and John Vissing and Heinz Wiendl and Nowak, {Richard J} and {International MG/COVID-19 Working Group}",
year = "2020",
month = may,
day = "15",
doi = "10.1016/j.jns.2020.116803",
language = "English",
volume = "412",
pages = "116803",
journal = "Journal of the Neurological Sciences",
issn = "0022-510X",
publisher = "Elsevier BV",

}

RIS

TY - JOUR

T1 - Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic

AU - Jacob, Saiju

AU - Muppidi, Srikanth

AU - Guidon, Amanda

AU - Guptill, Jeffrey

AU - Hehir, Michael

AU - Howard, James F

AU - Illa, Isabel

AU - Mantegazza, Renato

AU - Murai, Hiroyuki

AU - Utsugisawa, Kimiaki

AU - Vissing, John

AU - Wiendl, Heinz

AU - Nowak, Richard J

AU - International MG/COVID-19 Working Group

PY - 2020/5/15

Y1 - 2020/5/15

KW - Betacoronavirus

KW - Clinical Trials as Topic

KW - Coronavirus Infections/complications

KW - Disease Management

KW - Disease Susceptibility

KW - Humans

KW - Immunoglobulins, Intravenous/therapeutic use

KW - Immunologic Factors/therapeutic use

KW - Immunosuppressive Agents/therapeutic use

KW - Immunotherapy

KW - Lambert-Eaton Myasthenic Syndrome/complications

KW - Myasthenia Gravis/complications

KW - Pandemics

KW - Plasma Exchange

KW - Pneumonia, Viral/complications

KW - Vaccines

KW - COVID-19

KW - SARS-CoV-2

UR - http://www.scopus.com/inward/record.url?scp=85082716066&partnerID=8YFLogxK

U2 - 10.1016/j.jns.2020.116803

DO - 10.1016/j.jns.2020.116803

M3 - Journal article

C2 - 32247193

VL - 412

SP - 116803

JO - Journal of the Neurological Sciences

JF - Journal of the Neurological Sciences

SN - 0022-510X

M1 - 116803

ER -

ID: 61075256